Skip to main content
. 2016 Sep-Oct;48(5):591–594. doi: 10.4103/0253-7613.190761

Table 2.

Frequency of raised serum alanine transaminase level and hematological adverse effect profile in the study population

graphic file with name IJPharm-48-591-g002.jpg